JPWO2021101739A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021101739A5
JPWO2021101739A5 JP2022528970A JP2022528970A JPWO2021101739A5 JP WO2021101739 A5 JPWO2021101739 A5 JP WO2021101739A5 JP 2022528970 A JP2022528970 A JP 2022528970A JP 2022528970 A JP2022528970 A JP 2022528970A JP WO2021101739 A5 JPWO2021101739 A5 JP WO2021101739A5
Authority
JP
Japan
Prior art keywords
nos
seq
antibody
antibody fragment
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502387A5 (https=
JP2023502387A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059604 external-priority patent/WO2021101739A1/en
Publication of JP2023502387A publication Critical patent/JP2023502387A/ja
Publication of JPWO2021101739A5 publication Critical patent/JPWO2021101739A5/ja
Publication of JP2023502387A5 publication Critical patent/JP2023502387A5/ja
Pending legal-status Critical Current

Links

JP2022528970A 2019-11-19 2020-11-09 ジカウイルスを中和するヒト抗体およびその使用方法 Pending JP2023502387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962937603P 2019-11-19 2019-11-19
US62/937,603 2019-11-19
PCT/US2020/059604 WO2021101739A1 (en) 2019-11-19 2020-11-09 Human antibodies that neutralize zika virus and methods of use therefor

Publications (3)

Publication Number Publication Date
JP2023502387A JP2023502387A (ja) 2023-01-24
JPWO2021101739A5 true JPWO2021101739A5 (https=) 2023-11-06
JP2023502387A5 JP2023502387A5 (https=) 2023-11-06

Family

ID=75980179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528970A Pending JP2023502387A (ja) 2019-11-19 2020-11-09 ジカウイルスを中和するヒト抗体およびその使用方法

Country Status (8)

Country Link
US (1) US20230085393A1 (https=)
EP (1) EP4061422A4 (https=)
JP (1) JP2023502387A (https=)
KR (1) KR20220103761A (https=)
CN (1) CN115135345A (https=)
BR (1) BR112022009574A2 (https=)
CA (1) CA3158401A1 (https=)
WO (1) WO2021101739A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9562101B2 (en) * 2013-06-21 2017-02-07 Novartis Ag Lectin-like oxidized LDL receptor 1 antibodies and methods of use
WO2018010789A1 (en) * 2016-07-13 2018-01-18 Humabs Biomed Sa Novel antibodies specifically binding to zika virus epitopes and uses thereof
EP3534953A4 (en) * 2016-11-02 2020-10-07 Vanderbilt University ANTIBODIES AGAINST HUMAN ZIKA VIRUS AND THEIR USE PROCEDURES
US11370830B2 (en) * 2017-04-07 2022-06-28 The Rockefeller University Neutralizing antibodies that bind to the zika virus domain III envelope region

Similar Documents

Publication Publication Date Title
EP2582721B1 (en) Antibodies useful in passive influenza immunization
CN119735681A (zh) 优化的抗tl1a抗体
CN110317267B (zh) 针对狂犬病病毒的双特异性抗体及其用途
CN111615519B (zh) 结合人il-5的单克隆抗体、其制备方法和用途
CN113651888A (zh) Il-11的抗体及其应用
JPWO2021195418A5 (https=)
CN111153988B (zh) 广谱抗肠道病毒d68型的中和性单克隆抗体
WO2017121307A1 (zh) 一种C5aR抗体及其制备方法和应用
JPWO2021021605A5 (https=)
CN114195886A (zh) 抗hpv39 l1蛋白单克隆抗体及其制备与应用
CN104955839A (zh) 对人偏肺病毒具有特异性的人抗体或其抗原结合性片段
WO2022065445A1 (ja) ＳＡＲＳ－ＣｏＶ－２中和抗体又はその断片
CN113549147B (zh) 抗柯萨奇a6型病毒的单克隆抗体及其应用
CN114667297A (zh) 一种抗体融合蛋白及其制法和在抗肿瘤中的应用
CN116655785A (zh) 一种抑制寨卡病毒感染的单克隆抗体及其应用
JP2024509933A (ja) 抗水痘帯状疱疹ウイルスの抗体およびその使用
CN109206510B (zh) 与伪狂犬病病毒gB蛋白结合的单克隆抗体及其应用
JPWO2021101739A5 (https=)
CN110964104B (zh) 可结合hpv18病毒的蛋白质及其应用
CN114230659A (zh) 抗hpv53 l1蛋白单克隆抗体及其制备与应用
CN112574297B (zh) 抗神经氨酸酶的单克隆抗体及其应用
CN114773461B (zh) 乙型脑炎病毒抗体1d11及其应用
JPWO2021021830A5 (https=)
CN115260306B (zh) 靶向SARS-CoV-2受体结合基序的单克隆抗体及其识别抗原表位和应用
WO2022079359A1 (en) Sars-cov-2 coronavirus-neutralizing antibody